Federal · Title 21 — Food and Drugs
21 U.S.C. § 353a: Enhanced communication
Read the full statutory text
describing actions taken against compounding pharmacies, as described in subsection (b); or expressing concerns that a compounding pharmacy may be acting contrary to section 353a of this title . The issuance of a warning letter, or the imposition of sanctions or penalties, by a State for violations of a State’s pharmacy regulations pertaining to compounding. The suspension or revocation of a State-issued pharmacy license or registration for violations of a State’s pharmacy regulations pertaining to compounding. The recall of a compounded drug due to concerns relating to the quality or purity of such drug. The Secretary shall implement subsection (a) in consultation with the National Association of Boards of Pharmacy. the Secretary receives a submission under subsection (a)(1); or the Secretary makes a determination that a pharmacy is acting contrary to section 353a of this title .
Verify at the official source: Federal legislative text
Facing this? Know exactly what happens next.
MOFRD turns this code section into your situation: the deadlines that apply to you, the forms your county uses, and the resolution paths people in your position actually take. Free for 3 days — no card required.
This page is legal information, not legal advice. Code text is sourced from official publications and may lag amendments — always confirm at the official source linked above. Plain-English summaries and relationship data are AI-derived and reviewed on an ongoing basis; verify with a licensed attorney before acting.